Search clinical trials for: Dopaminergic Agonist Apomorphine

Total 13698 results

Rennes University Hospital

Completed

Evaluation of the Nonmotor Symptomatology of Parkinsonian Patients Treated With Two Strategies Related to Apomorphine Pump Therapy in French Hospitals (AGAPO)

Parkinson Disease

France
Rennes University Hospital

Completed

Efficacy of Continuous Apomorphine Infusion on Cognitive and Neuropsychological Functions in Parkinson's Disease (APO-TEP)

Parkinsons's Disease

France
Sunovion

Completed

A Study That Compares the Extent to Which Apomorphine Becomes Available in the Body After Taking Either an Investigational Drug Containing Apomorphine or Apomorphine That is Injected Under the Skin in People With PD Complicated by "OFF" Episodes

Parkinson Disease

United States
Sunovion

Completed

A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)

Motor OFF Episodes Associated With Parkinson's Disease

Spain, United Kingdom, Germany, Italy, Austria, France
University Hospital, Toulouse

Completed

Apomorphine Effect on Nociceptive Perception in Parkinson's: a Clinical and Imaging Study (APODOUL)

Parkinson's Disease

France
University Hospital, Rouen

Recruiting

Parkinsonian Patients Treated With Apomorphine Pump: Observatory of Skin Lesions (POLEMIC)

Patients With Parkinson's Disease Treated With Apomorphine Pumps

France
Oregon Health and Science University
National Institute of Neurological Disorders and Stroke (NINDS)

Withdrawn

Low Dose Apomorphine and Parkinsonism

Parkinson's Disease

United States
Alexza Pharmaceuticals, Inc.
ISS, Inc.; DSG; Peachtree BioResearch Solutions

Terminated

Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Parkinson's Disease Experiencing OFF Episodes

Parkinson Disease

United States
Mylan Bertek Pharmaceuticals

Completed

A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.

Parkinson Disease
Mylan Bertek Pharmaceuticals

Completed

Long Term Safety and Efficacy of SC Apomorphine in Treatment of "Off" Episodes in Late-Stage Parkinson's Disease

Parkinson Disease

United States
Hospital Universitari Vall d'Hebron Research Institute

Unknown

Relationship Between D2 Receptors SPECT and the Apomorphine Test in Patients With OH Dependence (ALC-DRD2-APO) (ALC-DRD2-APO)

Alcoholism

Spain
Mylan Bertek Pharmaceuticals

Completed

Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease

Parkinson Disease
University Hospital Inselspital, Berne
Czech Technical University in Prague

Recruiting

SPEECH as Biomarker for Emotion, Movement and cOgnition in Parkinson's Disease (EMO-SPEECH-PD)

Parkinson Disease

Switzerland, Czechia
University Hospital, Toulouse
Orkyn'; ELIVIE France; EVER Pharma France SAS; NHC SAS, France; ETPARK Association...

Recruiting

Personality and Quality of Life Amelioration After Continuous Subcutaneous Apomorphine Infusion in Parkinson's Disease (PERSO-PERF)

Parkinson Disease

France
Kyowa Kirin Co., Ltd.

Completed

Extended Long-Term Safety Study of KW-6500 (6500-005)

Parkinson's Disease

Japan
Kyowa Kirin Co., Ltd.

Completed

Long-Term Safety Study of KW-6500 in Patients With Parkinson's Disease

Parkinson's Disease

Japan
Britannia Pharmaceuticals Ltd.

Completed

Apomorphine Nasal Powder in the Treatment of Parkinson's Disease "Off" Periods.

Parkinson's Disease
Rambam Health Care Campus

Completed

Apomorphine Effects on Experimental Pain

Healthy

Israel
Kyowa Kirin Co., Ltd.

Completed

Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa Therapy

Parkinson's Disease

Japan
MDD US Operations, LLC a subsidiary of Supernus...

Active, not recruiting

Infusion of Apomorphine: Long-term Safety Study (INFUS-ON)

Idiopathic Parkinson's Disease

United States
Institut National de la Santé Et de la Recherche...

Completed

Blinking and Yawning in Epilepsy: The Role of Dopamine (BYE BYE DOPA)

Idiopathic Generalized Epilepsy

France
South Glasgow University Hospitals NHS Trust
Vectura Limited

Completed

Phase IIa Multicentre Study Investigating of VR040 in Parkinson's Disease (VR040/2/003)

Parkinson's Disease

United Kingdom, Serbia
University of Liege
Centre Hospitalier Neurologique William Lennox (Belgium); Hôpital Valdor -... and other collaborators

Recruiting

Apomorphine in Severe Brain-injured Patients (APODoC)

Disorder of Consciousness

Belgium, Spain
Mylan Bertek Pharmaceuticals

Completed

Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months

Parkinson Disease

United Kingdom
South Glasgow University Hospitals NHS Trust
Vectura Limited

Completed

Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's Disease

Parkinson's Disease

United Kingdom
William Ondo, MD
Sunovion

Not yet recruiting

Sublingual Apomorphine in Refractory Restless Legs Syndrome

Restless Legs Syndrome

United States
Sunovion

Completed

A Study to Examine APL-130277 in Patients With Parkinson's Disease

Parkinson's Disease

United States
University Hospital Inselspital, Berne
University Hospital, Geneva; Ecole Polytechnique Fédérale de Lausanne

Recruiting

Psychological Effects of Levodopa in Parkinson's Disease

Parkinson Disease

Switzerland
Sumitomo Pharma America, Inc.

Completed

Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

Parkinson Disease

United States, Spain, United Kingdom, Italy, Canada, Austria, France, Germany
Sunovion

Completed

Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's Disease

Parkinson Disease, Off Episodes

United States, Canada
Britannia Pharmaceuticals Ltd.

Completed

Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson's Disease (TOLEDO)

Parkinson's Disease

Spain, United Kingdom, Netherlands, Austria, Denmark, France, Germany
Kyowa Kirin Co., Ltd.

Completed

Placebo-Controlled Double-Blind Crossover Comparative Study of KW-6500 (6500-004)

Parkinson's Disease

Japan
University of Calgary
Paladin Labs Inc.

Recruiting

Apomorphine Effects on Pain in Parkinson's Disease

Parkinson Disease

Canada
Oregon Health and Science University
National Institute of Neurological Disorders and Stroke (NINDS)

Withdrawn

Comparison of Continuous and Pulsatile Apomorphine in Parkinson's Disease

Parkinson's Disease

United States
National Institute of Neurological Disorders and...

Completed

JP-1730 to Treat Parkinson's Disease

Parkinson Disease

United States
University of Liege
Université Catholique de Louvain

Active, not recruiting

Treating Severe Brain-injured Patients With Apomorphine

Disorder of Consciousness

Belgium
Assistance Publique - Hôpitaux de Paris

Active, not recruiting

Non-inferiority Trial Comparing Cloxacillin vs Cefazolin in Methicillin-susceptible Staphylococcus Aureus Bacteremia (CLOCEBA)

Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus

France
National Cancer Institute (NCI)

Completed

Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia

Barrett Esophagus | Esophageal Carcinoma

United States
Fondation Ophtalmologique Adolphe de Rothschild

Completed

Subcutaneous Apomorphine in the Treatment of Progressive Supranuclear Palsy and Cortico Basal Degeneration (APOPARKA) (APOPARKA)

Corticobasal Degeneration | Progressive Supranuclear Palsy

France
Fondation Ophtalmologique Adolphe de Rothschild

Terminated

Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE). (POMPRENELLE)

Parkinson's Disease

France
Duke University
National Institute of Mental Health (NIMH)

Recruiting

MRI Neurofeedback and Brain Circuits Related to Motivation in Healthy Participants

Motivation | Self-regulation | Memory

United States
Rambam Health Care Campus

Completed

The Effects of Apomorphine on Experimental and Clinical Pain in Patients With Chronic Radicular Pain

Chronic Low Back Pain

Israel
University Hospital, Toulouse
French Parkinson Association

Completed

Evaluation of the Role of the Noradrenergic System in Pain Perception in Parkinson's Disease (DOULOX)

Parkinson's Disease

France
iRegene Therapeutics Co., Ltd.

Recruiting

The Safety, Tolerability and Efficacy of NouvNeu001 for Parkinson's Disease

Parkinson Disease

China
University Medical Center Groningen

Terminated

Treatment of Apomorphine-induced Skin Reactions: a Pilot Study

Parkinson's Disease | Apomorphine-induced Skin Reactions

Netherlands
Radiation Therapy Oncology Group
National Cancer Institute (NCI)

Completed

Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Prostate Cancer

United States, Canada
Clinique Beau Soleil

Completed

Effect of Continuous Apomorphine During the Night on Sleep Disorders in Insomniac Patients With Parkinson's Disease (APOMORPHEE)

Parkinson Disease

France
NeuroHealing Pharmaceuticals Inc.
FDA Office of Orphan Products Development

Suspended

Efficacy Study of NH001 in Vegetative State & Minimally Conscious State Following a Traumatic Brain Injury (NH001-2)

Brain Injury

United States
University Medical Center Groningen

Unknown

Apomorphine in Parkinson's Disease Patients With Visual Hallucinations

Parkinson's Disease | Hallucinations, Visual

Netherlands
Rennes University Hospital

Recruiting

Monocentric, Prospective Study to Assess the Pharmacokinetic Profile of Continuous and Diurnal Subcutaneous Apomorphine Infusion in Patients With Parkinson's Disease (PHARM-APO)

Parkinson Disease

France

Search clinical trials for: Dopaminergic Agonist Apomorphine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations